These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 8086550)
1. Once-a-month administration of intravenous pentamidine to patients infected with human immunodeficiency virus as prophylaxis for Pneumocystis carinii pneumonia. Ena J; Amador C; Pasquau F; Carbonell C; Benito C; Gutiérrez F; Vilar A Clin Infect Dis; 1994 Jun; 18(6):901-4. PubMed ID: 8086550 [TBL] [Abstract][Full Text] [Related]
2. Long-term results of monthly inhaled pentamidine as primary prophylaxis of Pneumocystis carinii pneumonia in HIV-infected patients. Pretet S; Salmon D; Rousseau F; Guillon JM; Taki BE; Roux ME; Belguendouz A; Deleuze J; Morini JP; Gorin I Am J Med; 1993 Jan; 94(1):35-40. PubMed ID: 8420298 [TBL] [Abstract][Full Text] [Related]
3. [Prevention of Pneumocystis carinii pneumonia associated with HIV infection using pentamidine aerosols. Retrospective study of 465 cases]. Guinet F; Pialoux G; Trotot P; Chauvelle MT; Feuillie V; Sansonetti P; Dupont B Presse Med; 1994 Dec; 23(38):1747-52. PubMed ID: 7831262 [TBL] [Abstract][Full Text] [Related]
4. Intramuscular pentamidine for the prevention of Pneumocystis carinii pneumonia in patients infected with human immunodeficiency virus. Cheung TW; Matta R; Neibart E; Hammer G; Chusid E; Sacks HS; Szabo S; Rose D Clin Infect Dis; 1993 Jan; 16(1):22-5. PubMed ID: 8448314 [TBL] [Abstract][Full Text] [Related]
5. [Preventive pentamidine inhalation of Pneumocystis carinii pneumonia in patients with immune deficiency. Preliminary evaluation of a multicenter study]. Schrappe-Bächer M; Fätkenheuer G; Salzberger B; Zehrer I; Bendick C; Rasokat H Med Klin (Munich); 1990 Apr; 85 Suppl 2():276-80. PubMed ID: 2197537 [TBL] [Abstract][Full Text] [Related]
6. Two cases of Pneumocystis carinii pneumonia occurred in human immunodeficiency virus infected patients: supplemental treatment with aerosolised pentamidine isethionate. Goto H; Oka S; Mohri H; Kimura S; Mitamura K; Shimada K Jpn J Med; 1989; 28(1):105-9. PubMed ID: 2786100 [TBL] [Abstract][Full Text] [Related]
7. Low incidence of Pneumocystis carinii pneumonia in HIV patients receiving 300 mg pentamidine aerosol every 2 weeks. Kronawitter U; Bogner JR; Goebel FD Clin Investig; 1992 Dec; 70(12):1089-91. PubMed ID: 1467635 [TBL] [Abstract][Full Text] [Related]
8. Effect of aerosolized pentamidine prophylaxis on the diagnosis of Pneumocystis carinii pneumonia by induced sputum examination in patients infected with the human immunodeficiency virus. Levine SJ; Masur H; Gill VJ; Feuerstein I; Suffredini AF; Brown D; Lane HC; Yarchoan R; Shelhamer JH; Ognibene FP Am Rev Respir Dis; 1991 Oct; 144(4):760-4. PubMed ID: 1928945 [TBL] [Abstract][Full Text] [Related]
9. Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. The PRIO Study Group. Girard PM; Landman R; Gaudebout C; Olivares R; Saimot AG; Jelazko P; Gaudebout C; Certain A; Boué F; Bouvet E N Engl J Med; 1993 May; 328(21):1514-20. PubMed ID: 8479488 [TBL] [Abstract][Full Text] [Related]
10. Aerosolized pentamidine. Approved for HIV-infected individuals at high risk for Pneumocystis carinii pneumonia. Young FE; Nightingale SL; Cooper EC; Trapnell CB Arch Intern Med; 1989 Nov; 149(11):2412-3. PubMed ID: 2818104 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and effects on pulmonary function tests of weekly 600 mg aerosol pentamidine as prophylaxis against Pneumocystis carinii pneumonia. Ong EL; Dunbar EM; Mandal BK Infection; 1992; 20(3):136-9. PubMed ID: 1353750 [TBL] [Abstract][Full Text] [Related]
13. Prophylaxis and treatment of Pneumocystis carinii pneumonia. O'Doherty MJ; Bateman NT Br J Hosp Med; 1991 May; 45(5):277-8, 280, 283. PubMed ID: 1676607 [TBL] [Abstract][Full Text] [Related]
14. Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia. The San Francisco community prophylaxis trial. Leoung GS; Feigal DW; Montgomery AB; Corkery K; Wardlaw L; Adams M; Busch D; Gordon S; Jacobson MA; Volberding PA N Engl J Med; 1990 Sep; 323(12):769-75. PubMed ID: 1975426 [TBL] [Abstract][Full Text] [Related]
15. A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group. Schneider MM; Hoepelman AI; Eeftinck Schattenkerk JK; Nielsen TL; van der Graaf Y; Frissen JP; van der Ende IM; Kolsters AF; Borleffs JC N Engl J Med; 1992 Dec; 327(26):1836-41. PubMed ID: 1360145 [TBL] [Abstract][Full Text] [Related]
16. [Primary and secondary prevention of Pneumocystis carinii pneumonia with pentamidine aerosol. Effectiveness, side effects and incidence of extrapulmonary Pneumocystis carinii manifestations]. Stoehr A; Plettenberg A; Albrecht H; Stellbrink HJ; Meigel W; Begemann F Med Klin (Munich); 1994 Mar; 89(3):132-5. PubMed ID: 8196573 [TBL] [Abstract][Full Text] [Related]